Constipation: common but manageable Constipation is frequently reported with GLP-1 therapy and may worsen with: Low fibre intake Reduced food intake Inadequate hydration A sedentary lifestyle Helpful measures may include: Adequate water intake Fibre-rich fruits and vegetables Walking or light physical activity Isabgol or fibre supplementation if medically appropriate To reduce nausea, many patients find relief by switching to lighter regional Indian meals and smaller portions during the first few weeks
A new front in biotech rivalry
In Pulaski, this might be the option if single-agonist medications haven't met your weight loss goals
Appears to enhance weightloss and glucose effects when combined with GLP1, based on dualagonist data (such as tirzepatide). Glucagon receptor activation Increases energy expenditure and promotes fat oxidation when balanced properly with GLP1 and GIP. May help reduce liver fat and visceral (deep abdominal) fat, which are strongly linked to cardiometabolic risk. By combining these three pathways, retatrutide aims to reduce appetite, improve metabolic control, and increase calorie burning more strongly than current single or dualagonist drugs
Failed prior treatments: Documentation of at least two of the following for a minimum of 6 months each: structured weight loss program with documented adherence, vitamin E 800 IU daily, pioglitazone 30-45 mg daily, or other insulin sensitizer
Supports clear airways and easy breathing NAC thins mucus and promotes healthy respiratory function during seasonal challenges
